| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.1991.9.3.371 |
| P698 | PubMed publication ID | 1999706 |
| P2093 | author name string | J R Bertino | |
| F Richards | |||
| C A Davis | |||
| R L Capizzi | |||
| D N Pasquale | |||
| H J Durivage | |||
| J C Marsh | |||
| K H Katz | |||
| L R Farber | |||
| L S Rome | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| methotrexate | Q422232 | ||
| fluorouracil | Q238512 | ||
| P304 | page(s) | 371-380 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer | |
| P478 | volume | 9 |
| Q72425651 | 5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas) |
| Q28362939 | 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer |
| Q33424920 | A phase 1 clinical trial of sequential pralatrexate followed by a 48-hour infusion of 5-fluorouracil given every other week in adult patients with solid tumors |
| Q68234292 | A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions |
| Q44798254 | Adenovirus-mediated gene transfer of P16INK4/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo |
| Q36615696 | Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer. |
| Q36279281 | Barriers and strategies for effective chemotherapy |
| Q35993564 | Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo |
| Q34272629 | Exploring drug combinations in genetic interaction network |
| Q42280497 | INDI: a computational framework for inferring drug interactions and their associated recommendations |
| Q67743972 | Keynote address: Biochemical modification of therapeutic response |
| Q52170109 | Mechanisms of Action and Modulation of Fluorouracil. |
| Q73850415 | Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinoma |
| Q74202132 | Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate in patients with advanced colorectal cancer. Results of a phase II study |
| Q41440111 | Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes |
| Q73504130 | Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer |
| Q36695781 | Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil |
| Q70535295 | Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma |
| Q73203643 | Role of interferon as a modulator of fluoropyrimidines: reply to a recent editorial |
| Q73355992 | Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers |
| Q24792125 | Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study |
| Q70565415 | Systemic treatment of colorectal cancer |
| Q39428385 | Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA. |
| Q34436908 | The drug cocktail network |
| Q47643487 | Treatment of advanced colorectal cancer with 5-fluorouracil and interferon-α: An overview of clinical trials |
| Q92100170 | miR-770-5p modulates resistance to methotrexate in human colorectal adenocarcinoma cells by downregulating HIPK1 |
Search more.